Safety
Medical Cannabis for Depression in Australia — What the 2026 Evidence Says
A balanced, evidence-based look at medical cannabis for depression in Australia — the 2026 University of Sydney review findings, who it might help, CBD vs THC for mood, how to access a prescription, and safety warnings.
Depression is Australia’s third leading cause of disability, costing the nation more than $12.8 billion in healthcare costs and lost productivity each year. Approximately one in five Australians will experience mental illness in any given year, and depression — alongside anxiety — is among the most prevalent.
Given how common depression is and how many people find conventional treatments inadequate, it’s no surprise that a growing number of Australians are exploring medicinal cannabis as an alternative or complement to antidepressants and therapy.
But does the evidence support it? The honest answer is: it’s complicated.
What the research says in 2026
A landmark study published in early 2026 by researchers at the University of Sydney examined 54 randomised controlled trials — conducted between 1980 and 2025 — looking at whether medicinal cannabis reduced symptoms of depression, anxiety and PTSD. Their conclusion: there is currently no strong evidence that medicinal cannabis effectively treats these conditions in a clinical sense.
This is an important finding to acknowledge honestly. It doesn’t mean cannabis has no effect on mood — many people report meaningful personal benefit. It means the scientific gold standard (large, well-designed randomised controlled trials) hasn’t yet confirmed what many users experience anecdotally.
The evidence picture is evolving. Researchers at the Lambert Initiative for Cannabinoid Therapeutics (UNSW) are currently running clinical trials specifically examining CBD for anxiety. Early results from smaller studies are promising.
How cannabis may support mood — the biological mechanisms
Even without definitive clinical proof for depression specifically, we know quite a bit about how cannabis interacts with the brain systems involved in mood:
The endocannabinoid system and depression
The brain contains a network of receptors called the endocannabinoid system (ECS), which plays a key role in regulating mood, stress response, appetite and sleep. Some research suggests that depression may be associated with underactivity in this system — and that cannabinoids like THC and CBD can modulate it.
CBD and serotonin
CBD appears to interact with 5-HT1A serotonin receptors — the same receptors targeted by many antidepressant medications. This has led researchers to hypothesise that CBD may have antidepressant-like properties, though human clinical trial evidence is still limited.
Sleep and mood: an indirect pathway
One of the clearest indirect pathways is through sleep. Depression and sleep disruption are deeply intertwined — poor sleep worsens depression, and depression worsens sleep. Cannabis (particularly indica-dominant strains and CBD) can meaningfully improve sleep quality for many people, which may have secondary mood benefits.
What types of cannabis are used for depression support in Australia?
Australian clinicians and patients exploring cannabis for mood support typically focus on:
CBD-dominant products
CBD’s interaction with serotonin receptors and its anti-anxiety properties make it the most widely recommended starting point for mood-related conditions. CBD carries no intoxication risk and has a very favourable safety profile.
Common CBD formats:
- Oils/tinctures (under-the-tongue drops for precise dosing)
- Capsules (convenient, consistent)
- Topicals (for localised use — not mood-affecting)
Balanced THC/CBD products (1:1 ratios)
Products with roughly equal THC and CBD may help some people find a “sweet spot” — enough THC for mood elevation and relaxation, with CBD moderating the risk of anxiety or intoxication.
Indica-dominant strains for sleep
For depression that manifests strongly through sleep disruption and low energy, evening use of a mild indica strain or edible may support better sleep, which in turn supports mood.
Who might benefit from cannabis for depression?
Based on current Australian clinical practice patterns, cannabis may be considered for depression in people who:
- Have treatment-resistant depression — those who have tried two or more antidepressants without adequate response
- Experience depression alongside chronic pain — cannabis has stronger evidence for pain, and pain relief can reduce depression
- Have comorbid anxiety or insomnia alongside their depression — these overlap significantly and cannabis may address multiple symptoms simultaneously
- Prefer a natural or plant-based approach and are not finding adequate relief from pharmaceutical antidepressants
- Are under medical supervision and able to monitor their response carefully
Who should be cautious
Cannabis for depression is not appropriate for everyone. Exercise caution or avoid if:
- You have a personal or family history of psychosis or schizophrenia — high-THC cannabis can precipitate psychotic episodes in predisposed individuals
- You are under 25 — cannabis use before the brain is fully developed is associated with increased risk of depression and anxiety paradoxically
- You are pregnant or breastfeeding
- You are taking MAOIs or other high-interaction medications (see our guide on cannabis and antidepressants)
- You are in an acute depressive crisis — cannabis is not a substitute for urgent mental health care
How to access medicinal cannabis for depression in Australia
As of 2026, GPs in Australia can prescribe medicinal cannabis directly (without specialist referral) via the TGA’s Special Access Scheme. If you believe medicinal cannabis may help your depression:
- Book a GP appointment and be open about your symptoms and what you’ve tried
- Describe specifically how your depression manifests — sleep issues? anxiety? pain? appetite?
- Ask about medicinal cannabis — your GP can apply for approval through the TGA if clinically appropriate
- Be prepared for a holistic approach — cannabis works best alongside therapy, not as a replacement for it
If your regular GP is not familiar with medicinal cannabis prescribing, specialist telehealth cannabis clinics are also available in Australia.
The honest bottom line
Medical cannabis may offer real benefits for some people with depression — particularly through improving sleep, reducing anxiety, and supporting mood regulation via the endocannabinoid system. But it is not a proven, first-line depression treatment and should not replace evidence-based therapies like CBT, medication management or psychiatric care.
If you are experiencing depression, seek help from your GP or a mental health professional first. Cannabis can be part of a broader wellness approach — but it works best when combined with professional support, not as a standalone solution.
The most important thing: don’t manage severe depression alone. If you are in crisis, contact Lifeline on 13 11 14 or Beyond Blue on 1300 22 4636.
For educational purposes only. The Cannabis Shop makes no therapeutic claims about any product. This content does not constitute medical advice.
Explore our CBD topicals, edibles and full product range to find options that may support your wellbeing as part of a balanced lifestyle.